跳至主要内容
临床试验/JPRN-UMIN000050670
JPRN-UMIN000050670招募中Unknown

Exploration of biomarkers to predict the effects of anti TSLP antibody (Tezepelumab) in refractory asthma patients using comprehensive analyses of changes in gene expression in whole blood cells - Exploration of biomarkers to predict the effects of anti TSLP antibody (Tezepelumab) in refractory asthma patients using comprehensive analyses of changes in gene expression in whole blood cells

Department of Respiratory Medicine, University of Tsukuba0 个研究点目标入组 50 人开始时间: 2023年4月21日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with serious complications such as uncontrolled heart disease, diabetes mellitus, or gastrointestinal hemorrhage 2. Patients with active local or systemic infection requiring treatment 3. Patients with a history of serious hypersensitivity 4. Patients whose enrollment in this study is considered to be difficult due to clinically significant psychiatric disorders 5. Other patients considered ineligible for this study by the principal investigator/sub-investigator

研究者

发起方
Department of Respiratory Medicine, University of Tsukuba

相似试验